Sanara MedTech stock tracks merger approval and October 15 deadline
Published on 10/04/2026 at 12:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Sanara MedTech stock (ISIN US79957L1008) closed at USD 34.85 on Nasdaq on October 2, 2026, 1.4 percent below its 52-week high of USD 35.34. The latest corporate milestone is shareholder approval of the proposed MiMedx merger, with the next regulatory deadline set for October 15, 2026.
Shareholders approve merger
According to StockTitan on September 30, 2026, Sanara shareholders approved the merger proposal and the related executive compensation proposal. Proposal 1 received 6,372,989 votes for, 1,944 against and 36,494 abstentions, while 6,411,427 shares were represented at the meeting.
The regulatory timetable remains the key transaction variable. MiMedx and Sanara refiled their HSR notification on September 15, 2026, starting a new 30-calendar-day waiting period that is scheduled to expire at 11:59 p.m. ET on October 15, 2026, unless extended or ended early, according to StockTitan.
Revenue grows, earnings stay negative
Sanara reported Q2 2026 revenue of USD 28.14 million, up 9 percent from USD 25.8 million in Q2 2025, while diluted EPS was a USD 0.05 loss. The quarterly result also missed the cited consensus loss of USD 0.02, a gap that keeps operating performance relevant while merger clearance advances, as reported by MarketBeat.
Analysts see limited price distance
MarketBeat lists a Reduce consensus from five brokerages, comprising four holds and one sell, with an average 12-month price target of USD 35.00. Against the October 2 closing price of USD 34.85, that target lies 0.4 percent above the price, leaving the merger timetable more material than the published target gap.
Stock stays near yearly high
Sanara MedTech stock closed at USD 34.85 on October 2, 2026, with a daily change of -0.09 percent, volume of 341,850 shares and a market capitalization of USD 320.4 million. Its 52-week range was USD 16.05 to USD 35.34, placing the reference price near the upper end of the range while the October 15 HSR date approaches.
Sanara MedTech stock snapshot
- Company: Sanara MedTech Inc.
- ISIN: US79957L1008
- Ticker: SMTI
- Trading venue: Nasdaq Capital Market
- Price (as of October 2, 2026, 4:00 p.m. ET): USD 34.85, closing price
- Market capitalization: USD 320.4 million (as of October 2, 2026)
- 52-week range: USD 16.05-35.34 (as of October 2, 2026)
- Sector / Industry: Healthcare / Medical Instruments and Supplies
Upcoming dates for Sanara MedTech stock
- October 15, 2026: HSR waiting period expiration at 11:59 p.m. ET, unless extended or ended early
